Reach Us +1-504-608-2390
Editor - Maurizio Chiriva | Texas Tech University | 1838
ISSN: 2155-9899

Journal of Clinical & Cellular Immunology
Open Access

Like us on:

Our Group organises 3000+ Global Conferenceseries Events every year across USA, Europe & Asia with support from 1000 more scientific Societies and Publishes 700+ Open Access Journals which contains over 50000 eminent personalities, reputed scientists as editorial board members.

Open Access Journals gaining more Readers and Citations
700 Journals and 15,000,000 Readers Each Journal is getting 25,000+ Readers

This Readership is 10 times more when compared to other Subscription Journals (Source: Google Analytics)

Maurizio Chiriva

Maurizio Chiriva
Maurizio Chiriva
Director of Basic Research/Translational Research Program
Division of Hematology/Oncology
Texas Tech University Health Sciences Center
Texas Tech University


Upon completion of his degree as a doctor of biological sciences at the University of Milan Italy in 1996. Chiriva Internati held a postdoctoral position in the Myeloma and Transplantation Research Center at the University of Arkansas for Medical Sciences in Little Rock and successive junior faculty positions at the University of Alabama at Birmingham and at the Albany Medical College Albany New York. He frequently serves on national and international study sections and he is an active reviewer for several high impact factor journals such as: the Journal of Immunotherapy the Journal of Immunology Vaccine Leukemia Cancer Research Clinical Cancer Research Cancer Immunology and Immunotherapy the Journal of Translational Medicine and Lancet Infection Disease Most notably he is a Senior Editor for the Journal of Translational Medicine and Senior Editor for the International Reviews of Immunology.

Research Interest

Immunotherapeutic strategies for solid and non-solid tumors